Latest News about GSK
Recent news which mentions GSK
Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
December 07, 2021
From MarketWatch
Investors Do A Little Holiday Value Shopping On Monday
December 07, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
December 07, 2021
Tickers
GSK
From Benzinga
From Benzinga
From MarketWatch
3 Must-Own Dividend Stocks in This Chaotic Market
December 06, 2021
From Motley Fool
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
From Motley Fool
Why Jim Cramer Likes Enbridge, Vir Biotechnology And More
December 03, 2021
From Benzinga
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
December 02, 2021
From InvestorPlace
White House plans at-home COVID-19 testing blitz for winter, and Germany to lock down its unvaccinated
December 02, 2021
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
From Benzinga
From MarketWatch
VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial
December 02, 2021
From Benzinga
Britain Agrees To New Deals For 114M Additional Moderna, Pfizer/BioNTech COVID-19 Vaccine Doses
December 02, 2021
From Benzinga
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
December 02, 2021
From Benzinga
Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
December 01, 2021
From Benzinga
Why Did HC Wainwright Beef Up Vir Biotech's Target Price?
November 30, 2021
From Benzinga
Better Pharma Stock: GlaxoSmithKline vs. Bristol-Myers Squibb
November 30, 2021
From Motley Fool
From MarketWatch
VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.
November 30, 2021
From InvestorPlace
From Benzinga
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
November 29, 2021
From Motley Fool
Who Would Be the Best FDA Commissioner for Biotech Investors?
November 28, 2021
From Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
From Benzinga
GlaxoSmithKline Pens $1B Pact For NASH Candidate With Arrowhead
November 23, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.